Custom service
Targeting Peptide Modification and Conjugation
Modify targeting peptides for stability and conjugate them to payloads
The service is built around cyclization and D-residue stabilization. Depending on the molecule we may move to PEG-spacer payload attachment or chelator and dye installation to improve stability, loading or yield, and every batch is released with modified or conjugated targeting peptide with loading QC.
Because Targeting Peptide Modification and Conjugation projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
Attaching targeting motifs to drugs, beads or nanoparticles
Stabilizing motifs against serum proteases
Conjugations where the payload destroys receptor binding
Targets whose soluble ectodomain cannot be produced or sourced for binding assays
Binding affinity and specificity data are generated in-house for every campaign: IC50 or Kd against the intended target, plus counterscreens against the closest homologs. Release also includes purity, identity and, for conjugated variants, loading ratio.
Service Highlights
- Cyclization and D-residue stabilization as the default route, with PEG-spacer payload attachment held as a proven fallback
- Chelator and dye installation worked into the design where the application requires it
- Receptor-binding assays run against the intended target before any scale-up
- Analytical confirmation of every intermediate before the final release
- Specificity is measured against a negative-cell or negative-receptor panel, not asserted
- Modified or conjugated targeting peptide with loading QC delivered with a complete conjugation or synthesis certificate
How the work runs
Target analysis
We map the binding site, receptor biology and homolog panel that the Targeting Peptide Modification and Conjugation campaign must respect.
Motif selection or discovery
A motif is selected from literature, or discovered by screening, and candidate sequences are ranked.
Synthesis & modification
Candidates are synthesized with cyclization and D-residue stabilization applied to stabilize or direct the motif.
Binding & specificity testing
Affinity is measured on the target and counterscreens run on homologs and irrelevant cells.
Optimization round
Sequences are iterated — alanine scanning, truncation, D-substitution — until the specification is met.
Scale-up & release
The final variant is produced in quantity and Modified or conjugated targeting peptide with loading QC is released with the full data package.
Specifications & timeline
- Turnaround
- 4–6 weeks
- Typical scale
- 1 – 100 mg targeting peptide
- Chemistry options
- cyclization and D-residue stabilization; PEG-spacer payload attachment; chelator and dye installation
- Deliverable
- Modified or conjugated targeting peptide with loading QC
- QC package
- HPLC purity, MS identity, binding assay report
- Shipping
- Ambient or blue ice as stability requires
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.